The idea for the Deep Dive sessions was hatched at the 2018 Summit. One of the big pharma attendees commented that he could see other biopharmas all around him, but he wasn’t able to interact with enough of them on specific topics of common interest. In 2019 we are changing that with the addition of the Deep Dive sessions to provide the “big value in small group discussions” that is necessary in times of industry transformation.
Concurrent sessions focused on Clinical Development, Data Management, and Discovery will provide an opportunity for attendees to collaborate and problem-solve while maintaining their need to compete and innovate individually.
Each session will be led by an industry expert who will kick off the conversation with a brief case study example. This will be followed by a group brainstorming discussion of ideas and options around how best to achieve specific outcomes and overcome constraints focused on specific use cases.
Due to the small group and interactive nature of these sessions, we are offering attendees who register by May 31, 2019 a guaranteed reserved seat in the Deep Dive session of their choice. After May 31st, seating will be on a first come, first served basis at the Summit.